Gene · 865
Papers3,690
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,690
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune-related lncRNAs pairs prognostic score model for prediction of survival in acute myeloid leukemia patients. | Clin Exp Med | 2023 | 37233879 | PubTator, text mining | PubMed |
| Reprogramming of Acute Myeloid Leukemia Patients Cells: Harboring Cancer Mutations Requires Targeting of AML Hierarchy. | Stem Cells Transl Med | 2023 | 37226319 | PubTator, text mining | PubMed |
| Characterization of leukemia progression in the Cbfb-MYH11 knockin mice by single cell RNA sequencing. | Leukemia | 2023 | 37225965 | PubTator, text mining | PubMed |
| Profiling Immunological Phenotypes in Individuals During the First Year After Traumatic Spinal Cord Injury: A Longitudinal Analysis. | J Neurotrauma | 2023 | 37221869 | PubTator, text mining | PubMed |
| TAp63, a methotrexate target in CD4+ T cells, suppresses Foxp3 expression and exacerbates autoimmune arthritis. | JCI Insight | 2023 | 37212280 | PubTator, text mining | PubMed |
| Quantification of subtype purity in Luminal A breast cancer predicts clinical characteristics and survival. | Breast Cancer Res Treat | 2023 | 37209182 | PubTator, text mining | PubMed |
| Identification of a potential competing endogenous RNA (ceRNA) network in gastric adenocarcinoma. | J Gastrointest Oncol | 2023 | 37201096 | PubTator, text mining | PubMed |
| Expression of FBXW11 in normal and disease-associated osteogenic cells. | J Cell Mol Med | 2023 | 37199076 | PubTator, text mining | PubMed |
| Inducible MLL-AF9 Expression Drives an AML Program during Human Pluripotent Stem Cell-Derived Hematopoietic Differentiation. | Cells | 2023 | 37190104 | PubTator, text mining | PubMed |
| p53 Deficiency-Dependent Oncogenicity of Runx3. | Cells | 2023 | 37190031 | PubTator, text mining | PubMed |
| The RUNX Family of Proteins, DNA Repair, and Cancer. | Cells | 2023 | 37190015 | PubTator, text mining | PubMed |
| Association between Immunophenotypic Parameters and Molecular Alterations in Acute Myeloid Leukemia. | Biomedicines | 2023 | 37189716 | PubTator, text mining | PubMed |
| Epithelial to mesenchymal transition in mammary gland tissue fibrosis and insights into drug therapeutics. | PeerJ | 2023 | 37187521 | PubTator, text mining | PubMed |
| Harnessing and honing mesenchymal stem/stromal cells for the amelioration of graft-versus-host disease. | World J Stem Cells | 2023 | 37180998 | PubTator, text mining | PubMed |
| Clinical Significance of microRNAs in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation. | Cancers (Basel) | 2023 | 37174123 | PubTator, text mining | PubMed |
| Single-Cell Next-Generation Sequencing to Monitor Hematopoietic Stem-Cell Transplantation: Current Applications and Future Perspectives. | Cancers (Basel) | 2023 | 37173944 | PubTator, text mining | PubMed |
| Venetoclax combined with daunorubicin and cytarabine (2 + 6) as induction treatment in adults with newly diagnosed acute myeloid leukemia: a phase 2, multicenter, single-arm trial. | Exp Hematol Oncol | 2023 | 37173750 | PubTator, text mining | PubMed |
| Identification and analysis of hub genes of hypoxia-immunity in type 2 diabetes mellitus. | Front Genet | 2023 | 37153000 | PubTator, text mining | PubMed |
| Profiling the Somatic Mutational Landscape of Breast Tumors from Hispanic/Latina Women Reveals Conserved and Unique Characteristics. | Cancer Res | 2023 | 37145128 | PubTator, text mining | PubMed |
| Beyond VEGF: Targeting Inflammation and Other Pathways for Treatment of Retinal Disease. | J Pharmacol Exp Ther | 2023 | 37142441 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/865/papers?page=15